Macarena P. Hayashi-Quintana

BioPharmaceuticals R&D, AstraZeneca
Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.

Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA Trial.

Journal: Circulation

Published: August 30, 2026

Phase 2b trial of an oral relaxin family peptide receptor 1 agonist in patients with chronic heart failure: rationale and design.

Phase 2b trial of an oral relaxin family peptide receptor 1 agonist in patients with chronic heart failure: rationale and design.

Journal: ESC heart failure

Published: August 29, 2025

Treatment with (R)-α-methylhistamine or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach.

Treatment with (R)-α-methylhistamine or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach.

Journal: Virulence

Published: July 16, 2025

A Phase 1b Randomized Clinical Trial of AZD5462 and Dapagliflozin in Patients with Heart Failure and Moderate Renal Impairment.

A Phase 1b Randomized Clinical Trial of AZD5462 and Dapagliflozin in Patients with Heart Failure and Moderate Renal Impairment.

Journal: The American journal of cardiology

Published: June 24, 2025

Detection of Bacterial Adhesion to Mucus Slot-Blotted on Polyvinylidene Difluoride (PVDF) Membrane.

Detection of Bacterial Adhesion to Mucus Slot-Blotted on Polyvinylidene Difluoride (PVDF) Membrane.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: June 11, 2025

Re-PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients.

Re-PERFUSE: Phase 1b study of AZD3427, a novel relaxin receptor agonist, on renal perfusion in HFrEF patients.

Journal: ESC heart failure

Published: May 15, 2025

In Atlantic salmon skin infested with salmon lice, elevated seawater temperatures change gene expression and mucus glycosylation, which promotes pathogen binding.

In Atlantic salmon skin infested with salmon lice, elevated seawater temperatures change gene expression and mucus glycosylation, which promotes pathogen binding.

Journal: Fish & shellfish immunology

Published: March 05, 2025

Aeromonas salmonicida AI-1 and AI-2 quorum sensing pathways are differentially regulated by rainbow trout mucins and during in vivo colonization.

Aeromonas salmonicida AI-1 and AI-2 quorum sensing pathways are differentially regulated by rainbow trout mucins and during in vivo colonization.

Journal: Fish & shellfish immunology

Published: January 28, 2024

Differentiation of Pig Gastric Primary Cells into Mucus Producing Epithelial Cells.

Differentiation of Pig Gastric Primary Cells into Mucus Producing Epithelial Cells.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 22, 2023

In vitro fish mucosal surfaces producing mucin as a model for studying host-pathogen interactions.

In vitro fish mucosal surfaces producing mucin as a model for studying host-pathogen interactions.

Journal: PloS one

Published: June 25, 2023

Porcine intestinal glycosphingolipids recognized by Brachyspira hyodysenteriae.

Porcine intestinal glycosphingolipids recognized by Brachyspira hyodysenteriae.

Journal: Microbial pathogenesis

Published: October 18, 2022

Mucin O-glycosylation and pathogen binding ability differ between rainbow trout epithelial sites.

Mucin O-glycosylation and pathogen binding ability differ between rainbow trout epithelial sites.

Journal: Fish & shellfish immunology

Published: June 30, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026